The full speaker list for this conference has not yet been announced. Please check back in the coming weeks and months for updates to this list.

Vincent G. Brichard, MD, Vice President & Head of Immunotherapeutics, GSK Biologicals

Franco Marincola, MD, Chief, Infectious Disease and Immunogenetics Section, National Cancer Institute, National Institutes of Health

Candice McCoy, MD, Sr. Medical Director, Dendreon Corporation

Teresa Ramirez-Montagut, MD, Ph.D., Research Investigator, Cancer Vaccine Initiative, Genomics Institute of the Novartis Research Foundation

Kim Margolin, MD, Professor, University of Washington School of Medicine

Lisa Butterfield, Ph.D., Associate Professor, Departments of Medicine, Surgery, and Immunology, Director, UPCI Immunologic Monitoring and Cellular Products Laboratory, University of Pittsburgh School of Medicine

Mara Goldstein, Senior Healthcare Analyst, Cantor Fitzgerald

Richard Koya, MD, Ph.D., Assistant Professor, Department of Surgery, Surgical Oncology, Member, JCCC Tumor Immunology Program Area, Jonsson Comprehensive Cancer Center (JCCC), University of California, Los Angeles

Ena Wang, MD, Director of Molecular Science, Infectious Diseases and Immunogenetics Section, Department of Transfusion Medicine, CC, National Institutes of Health

Steffen Walter, Ph.D., Head of Immunology, Immatics Biotechnologies

Andrew Cornforth, Ph.D., Cancer Stem Cell Program Manager, California Stem Cell

Richard Harrop, D.Phil., Head of Clinical Analysis, Oxford BioMedica

Mark J. Ahn, Ph.D., President and Chief Executive Officer, Galena Biopharma

Adrian Bot, MD, Ph.D., Chief Scientific Officer, Kite Pharma, Inc.

Jeffrey Schlom, Ph.D., Head, Immunotherapeutics Group Laboratory Chief, National Cancer Institute, Laboratory of Tumor Immunology & Biology

Pramod Srivastava, Ph.D., MD, Professor of Immunology, Physicians Health Services Chair in Cancer Immunology, Director, Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut Health Center

Graham Pawelec, Ph.D., Professor of Experimental Immunology and Head of the Tuebingen Tumour Immunology and Ageing Group (TATI), University of Tuebingen Medical School

Dirk Brockstedt, Ph.D., VP Research and Development, Aduro BioTech

W. Martin Kast, Ph.D., Professor of Molecular Microbiology and Immunology, and Obstetrics and Gynecology, University of Southern California

Marnix Bosch, Ph.D., Chief Technical Officer, Northwest Biotherapeutics, Inc.

John Rothman, Ph.D., Executive VP of Science & Operations, Advaxis, Inc.

Punit Dhillon, President & Chief Executive Officer, OncoSec Medical Inc.